Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARISE
NCT07558135Not yet recruiting
- Sponsor
- King's College Hospital
- Start
- Sep 2026
- Primary completion
- Sep 2028
- Modality
- Small Molecules
01
Overview
Randomised trial of hydrocortisone in adrenal insufficiency (AI) (2 arms), sponsored by King's College Hospital. Primary endpoint: Incidence of Sustained Adrenal Insufficiency at 3 months. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
hydrocortisone
03
Conditions
adrenal insufficiency (AI)
Beyond the preview
Go deeper on NCT07558135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07558135.